Medipal HoldingsMAHLY +5.92%78 Current Ratio is 1.28 as of Mar. 2026, which is 5% above its 10-year median of 1.22. GuruFocus rates MAHLY with a GF Score™ of 78/100 and a GF Value™ of $16.44 (Fairly Valued). The stock has 1 warning sign investors should review. Among 118 Medical Distribution companies, Medipal Holdings ranks worse than 61.86% on this metric.
The current ratio is a liquidity ratio that measures a company's ability to pay short-term obligations. It is calculated as a company's Total Current Assets divides by its Total Current Liabilities. Medipal Holdings's current ratio for the quarter that ended in Mar. 2026 was 1.28.
Medipal Holdings has a current ratio of 1.28. It generally indicates good short-term financial strength.
The historical rank and industry rank for Medipal Holdings's Current Ratio or its related term are showing as below:
MAHLY'
s Current Ratio Range Over the Past 10 Years
Min: 1.18 Med: 1.22 Max: 1.28
Current: 1.28
During the past 13 years, Medipal Holdings's highest Current Ratio was 1.28. The lowest was 1.18. And the median was 1.22.
MAHLY's Current Ratio is ranked worse than 61.86% of 118
companies
in the Medical Distribution industry
Industry Median: 1.395
vs MAHLY: 1.28
Medipal Holdings (OTCPK:MAHLY) Current Ratio Explanation
The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.
Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.
The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.
If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.
Medipal Holdings Current Ratio Related Terms
Medipal Holdings Current Ratio Historical Data
* Premium members only.
The historical data trend for Medipal Holdings's Current Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Distribution subindustry, Medipal Holdings's Current Ratio, along with its competitors' market caps and Current Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medipal Holdings Current Ratio vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Medipal Holdings's Current Ratio distribution charts can be found below:
* The bar in red indicates where Medipal Holdings's Current Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medipal Holdings (MAHLY) has a Current Ratio of 1.28 as of Mar. 2026. This is near median its historical median of 1.22. Over the past decade, Medipal Holdings' Current Ratio has ranged from 1.18 to 1.28. According to the industry distribution chart, Medipal Holdings ranks #73 out of 118 companies in the Medical Distribution industry, placing it in the top 61.9%.
Is Medipal Holdings' Current Ratio too high?
Medipal Holdings' current Current Ratio of 1.28 is near median its 10-year median of 1.22. Over the past 10 years, this metric has ranged from a low of 1.18 to a high of 1.28. The Medical Distribution industry median Current Ratio is 1.40. Medipal Holdings' value of 1.28 is 8.2% below this industry median. Based on the distribution chart, Medipal Holdings ranks #73 out of 118 companies in the Medical Distribution industry, which is below the industry midpoint. Overall, Medipal Holdings has a GF Score™ of 78/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Medipal Holdings' Current Ratio compare to MCK and CAH?
According to the Medical Distribution industry distribution chart, Medipal Holdings ranks #73 out of 118 companies for Current Ratio. This places Medipal Holdings in the lower half of its industry. The industry median Current Ratio is 1.40. Medipal Holdings' value of 1.28 is 8.2% below this benchmark. Historically, Medipal Holdings' own Current Ratio has ranged from 1.18 to 1.28 over the past decade. While the company's 10-year median is 1.22 vs. the industry median of 1.40, Medipal Holdings has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Ratio for a Medical Distribution company?
The median Current Ratio among Medical Distribution companies is 1.40, based on 118 companies in the industry. Companies in the top quartile (top 25%) have a Current Ratio significantly above this median, while those in the bottom quartile fall well below. However, Current Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Medipal Holdings's current Current Ratio of 1.28 is 8.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Ratio mean?
A high Current Ratio can signal that a stock is expensive relative to its fundamentals. For the Medical Distribution industry, the median Current Ratio is 1.40 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medipal Holdings's current Current Ratio is 1.28, which is near median its own 10-year median of 1.22. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medipal Holdings stock overvalued right now?
Based on GuruFocus' analysis, Medipal Holdings (MAHLY) is currently considered Fairly Valued. The stock's GF Value™ is $16.44, compared to a current price of $16.28 — trading 1% below its estimated fair value. The current Current Ratio is 1.28, which is near median its 10-year median of 1.22 and 8.2% below the Medical Distribution industry median of 1.40. Medipal Holdings' overall GF Score™ is 78/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Ratio calculated?
Current Ratio is calculated from a company's financial statements. For Medipal Holdings (MAHLY), the current Current Ratio is 1.28 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Medipal Holdings (MAHLY) Overvalued in 2026?
Based on GuruFocus' analysis, Medipal Holdings stock appears to be undervalued.
The current stock price of $16.28 is trading 1% below its estimated GF Value™ of $16.44.
GuruFocus considers Medipal Holdings to be Fairly Valued.
Key valuation signals for MAHLY:
Current Ratio: 1.28 (near median its 10-year median of 1.22)
GF Value™: $16.44 vs. price of $16.28 (1% below fair value)
Industry Position: 8.2% below the Medical Distribution median (#73 of 118)
No single metric tells the full story. See the MAHLY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Medipal Holdings Corp is engaged in the wholesale distribution of pharmaceuticals, cosmetics, daily necessities, and related products. The company operates through three reportable segments: Wholesale business of medical drugs; Cosmetics, Daily Necessities and OTC Pharmaceuticals Wholesale Business; and Wholesale of animal medicines and food processing ingredients. The Wholesale business of medical drugs segment targets hospitals, clinics, and dispensing pharmacies; the Cosmetics and OTC segment serves drug stores, home centers, convenience stores, and supermarkets; while the Wholesale of animal medicines and food processing ingredients segment supplies veterinary clinics, livestock and fisheries businesses, and food manufacturers.
78GF Score
Get the complete analysis for MAHLY
Current Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MAHLY has been successfully added to your 
